Patients and HCP understanding on additonal monitoring

29/01/2021
29/01/2021
EU PAS number:
EUPAS39272
Study
Finalised
Study type

Study topic

Other

Study topic, other

To assess attitudes towards adverse drug reactions (ADR) reporting and reasons for not reporting an ADR and awareness of additional monitoring (AM) among HCPs, patients or their careers

Study type

Non-interventional study

Scope of the study

Other

If ‘other’, further details on the scope of the study

Assessment of awareness of additional monitoring

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Survey questionnaire
Population studied

Short description of the study population

Health care professionals (HCPs), patients or their careers in EU countries.

Age groups

  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

2918
Study design details

Main study objective

To assess (a) attitudes towards ADR reporting and reasons for not reporting an ADR and (b) awareness of AM among HCPs, patients or their careers in EU countries

Outcomes

To assess (a) attitudes towards ADR reporting and reasons for not reporting an ADR and (b) awareness of AM among HCPs, patients or their careers in EU countries

Data analysis plan

Survey responses analysis